ArticleKidney research and clinical practice2019

Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease.

Fizza Abbas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.